$116 Million is the total value of New Leaf Venture Partners, L.L.C.'s 14 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 17.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ARVN | ARVINAS INC | $32,005,911 | -9.2% | 1,289,521 | 0.0% | 27.49% | -5.6% | |
| RALLYBIO CORPORATION | $18,687,073 | -0.9% | 3,301,603 | 0.0% | 16.05% | +3.0% | ||
| DICE THERAPEUTICS INC | $17,268,857 | +62.2% | 371,693 | 0.0% | 14.83% | +68.5% | ||
| DCPH | DECIPHERA PHARMACEUTICALS INC | $17,030,760 | -8.9% | 1,209,571 | 0.0% | 14.63% | -5.3% | |
| EWTX | EDGEWISE THERAPEUTICS INC | $12,040,873 | +16.2% | 1,553,661 | 0.0% | 10.34% | +20.8% | |
| COGT | COGENT BIOSCIENCES INC. | $5,938,115 | +9.7% | 501,530 | 0.0% | 5.10% | +14.0% | |
| CRNX | CRINETICS PHARMACEUTICALS INC | $2,540,820 | +12.2% | 141,000 | 0.0% | 2.18% | +16.6% | |
| RCKT | ROCKET PHARMACEUTICALS INC | $2,349,469 | +16.0% | 118,242 | 0.0% | 2.02% | +20.5% | |
| PASG | PASSAGE BIO | $2,348,047 | -2.1% | 2,497,922 | 0.0% | 2.02% | +1.8% | |
| HARP | HARPOON THERAPEUTICS INC | $2,241,256 | -4.1% | 3,156,699 | 0.0% | 1.92% | -0.3% | |
| ALEC | ALECTOR INC | $2,040,810 | -2.9% | 339,569 | 0.0% | 1.75% | +0.9% | |
| ARAV | ARAVIVE INC | $1,192,493 | -37.0% | 946,423 | 0.0% | 1.02% | -34.5% | |
| XFOR | X4 PHARMACEUTICALS INC | $649,900 | +123.0% | 335,000 | 0.0% | 0.56% | +131.5% | |
| ITERUM THERAPEUTICS PLC | $103,880 | +7.0% | 97,084 | 0.0% | 0.09% | +11.2% | ||
| AVRO | Exit | AVROBIO INC | $0 | – | -315,550 | -100.0% | -0.26% | – |
| CMRX | Exit | CHIMERIX INC | $0 | – | -1,224,600 | -100.0% | -1.28% | – |
| AMYT | Exit | AMRYT PHARMA PLCsponsored ads | $0 | – | -449,737 | -100.0% | -5.42% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-08-10
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| DECIPHERA THERAPEUTICS INC | 25 | Q3 2023 | 44.4% |
| CHIMERIX INC | 25 | Q1 2023 | 20.9% |
| SIERRA ONCOLOGY INC | 22 | Q2 2022 | 14.9% |
| ARVINAS INC | 21 | Q3 2023 | 44.8% |
| CRINETICS PHARMACEUTICALS INC | 21 | Q3 2023 | 11.4% |
| OBSEVA SA | 20 | Q4 2021 | 8.5% |
| AVROBIO INC | 20 | Q1 2023 | 1.7% |
| HARPOON THERAPEUTICS INC | 19 | Q3 2023 | 20.0% |
| ALECTOR INC | 19 | Q3 2023 | 4.6% |
| ITERUM THERAPEUTICS PLC | 18 | Q3 2022 | 3.8% |
View New Leaf Venture Partners, L.L.C.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-10 |
| 13F-HR | 2023-05-11 |
| 13F-HR | 2023-02-06 |
| 13F-HR | 2022-11-10 |
| 13F-HR | 2022-08-09 |
| 13F-HR | 2022-05-06 |
| 13F-HR | 2022-02-11 |
| 13F-HR | 2021-11-12 |
View New Leaf Venture Partners, L.L.C.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.